🔥 Concentrated Flow (Market Close)
See full theme ranking and leading stocks →
Mycoplasma Pneumonia Stocks and Leader (Korea)
Updated: 2026.10.30 (market close)
The Mycoplasma Pneumonia theme has 20 member stock(s) today, with an average return of -1.5%. The leading stock is 위더스제약 (+1.3%, trading value 736,517,875).
Pediatric bacterial pneumonia theme, gaining attention when outbreak alerts trigger reports of surging demand for specific antibiotics and diagnostic kits.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 위더스제약 | 6,440 | +1.3% | 736,517,875 |
| 팜젠사이언스 | 2,765 | +0.6% | 56,916,905 |
| 젠큐릭스 | 1,957 | 0.0% | 0 |
| 진매트릭스 | 1,417 | -0.1% | 49,667,820 |
| 조아제약 | 1,705 | -0.2% | 52,990,821 |
| 수젠텍 | 4,055 | -0.7% | 169,597,555 |
| 엑세스바이오 | 1,905 | -0.8% | 46,619,843 |
| 경동제약 | 4,865 | -1.0% | 31,564,070 |
| 씨티씨바이오 | 2,605 | -1.1% | 56,601,262 |
| 씨젠 | 33,200 | -1.2% | 4,787,230,150 |
| 국전 | 2,050 | -1.2% | 273,899,300 |
| 광동제약 | 6,230 | -1.3% | 959,029,985 |
| 미래생명자원 | 1,656 | -1.8% | 56,339,514 |
| 녹십자엠에스 | 3,095 | -2.1% | 1,437,884,794 |
| 비씨월드제약 | 2,760 | -2.1% | 10,917,800 |
| 국제약품 | 3,320 | -2.3% | 1,258,769,824 |
| 휴마시스 | 2,300 | -3.6% | 200,098,643 |
| DXVX | 1,820 | -3.6% | 148,815,942 |
| 인트론바이오 | 2,765 | -3.8% | 363,556,381 |
| 멕아이씨에스 | 1,367 | -4.1% | 42,766,738 |
This page's data is for reference only and is not investment advice. Actual market data may differ.